Skip to main content

Advertisement

SpringerLink
Log in

Evaluation of the Efficacy of Combined Continuous Arterial Infusion and Systemic Chemotherapy for the Treatment of Advanced Pancreatic Carcinoma

  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the effects of combined continuous transcatheter arterial infusion (CTAI) and systemic chemotherapy in patients with advanced pancreatic carcinoma.

Methods

CTAI was performed in 17 patients with stage IV pancreatic cancer with (n = 11) or without (n = 6) liver metastasis. The reservoir was transcutaneously implanted with the help of angiography. The inferior pancreatic artery (IPA) was embolized to achieve delivery of the pancreatic blood supply through only the celiac artery. The systemic administration of gemcitabine was combined with the infusion of 5-fluorouracil via the reservoir. Treatment effects were evaluated based on the primary tumor size, liver metastasis, and survival time and factors such as tumor size, tumor location, and stage of pancreatic carcinoma; the embolized arteries were analyzed with respect to treatment effects and prognosis.

Results

A catheter was fixed in the gastroduodenal artery and splenic artery in 10 and 7 patients, respectively. Complete peripancreatic arterial occlusion was successful in 10 patients. CT showed a decrease in tumor size in 6 of 17 (35%) patients and a decrease in liver metastases in 6 of 11 (55%) patients. The survival time ranged from 4 to 18 months (mean ± SD, 8.8 ± 1.5 months). Complete embolization of arteries surrounding the pancreas was achieved in 10 patients; they manifested superior treatment effects and prognoses (p < 0.05).

Conclusion

In patients with advanced pancreatic cancer, long-term CTAI with systemic chemotherapy appeared to be effective not only against the primary tumor but also against liver metastases. Patients with successfully occluded peripancreatic arteries tended to survive longer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3A–E.
Figure 4

Similar content being viewed by others

References

  1. Zimmerman SE, Smith FP, Scein PS (1981) Chemotherapy of pancreatic carcinoma. Cancer 47:1724

    CAS  PubMed  Google Scholar 

  2. Rosenberg JM, Welch JP, Macaulay WP (1985) Cancer of the head of the pancreas: An institutional review with emphasis on surgical therapy. J Surg Oncol 28:17

    Google Scholar 

  3. Connolly MM, Dawson PJ, Michelassi F, Moosa AR, Lowenstein F (1987) Survival in 1001 patients with adenocarcinoma of the pancreas. Ann Surg 206:366

    CAS  PubMed  Google Scholar 

  4. Nagakawa T, Kobayashi H, Ueno K, Ohta T, Kayahara M, Miyazaki (1994) Clinical study of the lymphatic flow to pancreatic lymph nodes in carcinoma of the head of the pancreas. Cancer 73:1155

    CAS  PubMed  Google Scholar 

  5. Moertel CG, Engstrom P, Lavin PT, Gelber RD, Carbone PP (1979) Chemotherapy of pancreatic and gastric carcinoma: A controlled evaluation of combination of 5-FU with nitrosoureas and “lactones”. Surgery 85:509

    CAS  PubMed  Google Scholar 

  6. Hansen R, Quebbeman E, Ritch P, Chitamber C, Anderson T (1988) Continuous 5-FU infusion in carcinoma of the pancreas. Am J Med Sci 295:91

    CAS  PubMed  Google Scholar 

  7. Auerbach M, Wampler GL, Lockich JJ, Fryer D, Fryer JG, Ahlgren JD (1997) Treatment of advanced pancreatic carcinoma with a combination of protracted infusional 5-FU plus weekly cisplatin for pancreatic carcinoma. A Mid Atlantic Oncology Program Study. Ann Oncol 8:439

    Article  CAS  PubMed  Google Scholar 

  8. Carmichael J (1997) Clinical response benefit in patients with advanced pancreatic cancer. Role of gemcitabine. Digestion 58:503

    CAS  PubMed  Google Scholar 

  9. Casper ES, Green MR, Kelsen DP, et al (1994) Phase II trial of gemicitabine (2’2’-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas. Invest New Drugs 12:29

    Article  CAS  PubMed  Google Scholar 

  10. Rothenberg ML, Moore MJ, Cripps MC, et al (1996) A phase II trial of gemicitabine in patients with 5-FU refractory pancreas cancer. Ann Oncol 7:347

    CAS  PubMed  Google Scholar 

  11. Burris HA, Moore MJ, Andersen J, et al (1997) Improvements in survival and clinical benefits gemicitabine as first-line therapy for patients with advanced pancreatic cancer. J Clin Oncol 15:2403

    CAS  PubMed  Google Scholar 

  12. Muchmore JH, Perslan JE, George WJ (1996) Regional chemotherapy for inoperable pancreatic carcinoma. Cancer 78 (3 Suppl):664

    CAS  PubMed  Google Scholar 

  13. Miura K, Wada T (1981) Clinical effects of hyperthermia in advanced malignancy; Preliminary clinical results of combined 2450 megahertz microwave therapy and head of pancreas. Gastroenterol Surg 4:181

    Google Scholar 

  14. Theodors A, Bukowski R, Hewlett J, Livingston RB, Weick JK (1982) Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Am J Clin Oncol 5:5555

    Google Scholar 

  15. Ohigashi H, Ishikawa O, Imaoka S, et al (1996) A new method of intra-arterial regional chemotherapy with more selective drug delivery for locally advanced pancreatic cancer. Hepato-Gastroenterol 43:338

    CAS  Google Scholar 

  16. Hiraska T, Watanabe E, Mochinaga M, et al (1984) Intraoperative radiation therapy for patients with pancreatic carcinoma. World J Surg 8:766

    Google Scholar 

  17. Foo ML, Gunderson LL, Nagorney DM, et al (1993) Pattern of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ± 5-fluorouracil. Int J Radiat Oncol Biol Phys 26:483

    CAS  PubMed  Google Scholar 

  18. Rosenberg JM, Welch JP, Macaulay WP (1985) Cancer of the head of the pancreas: An institutional review with the emphasis on surgical therapy. J Surg Oncol 28:217

    CAS  PubMed  Google Scholar 

  19. Niederhuber JE, Brennan MF, Menck HR (1995) The National Cancer Data Base Report on pancreatic cancer. Cancer 76:1671

    CAS  PubMed  Google Scholar 

  20. Splinter TAW, Obertop H, Kok TC, Jeekel J (1989) Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas: A nonrandomized pilot study. J Cancer Res Clin Oncol 115:200

    CAS  PubMed  Google Scholar 

  21. Bakkevold KE, Amesjo B, Dahl O, Kambestad B (1993) Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater: Results of a controlled, prospective randomized multicentre study. Eur J Cancer 29A:698

    CAS  PubMed  Google Scholar 

  22. Arbuck SG, (1990) Overview of chemotherapy for pancreatic cancer. Int J Pancreatol 7:209

    CAS  PubMed  Google Scholar 

  23. Wagener DJT, Hoogenraad WJ, Rougier P, et al (1996) Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer. An EORTC GITCCG study. Eur J Cancer 32A:1310

    CAS  PubMed  Google Scholar 

  24. Connolly MM, Dawson PJ, Michelassi F, Moosa AR, Lowenstein F (1987) Survival in 1001 patients with adenocarcinoma of the pancreas. Ann Surg 206:366

    CAS  PubMed  Google Scholar 

  25. Muchmore JH, Preslan JE, George WJ (1996) Regional chemotherapy for inoperable pancreatic carcinoma. Cancer 78:664

    CAS  PubMed  Google Scholar 

  26. Douglass H (1993) Current approaches to multimodality management of advanced pancreatic cancer. Hepato-Gastroenterol 40:433

    CAS  Google Scholar 

  27. Gudjonsson B (1995) Carcinoma of pancreas: Critical analysis of cost, results of resection, and the need for standardized reporting. J Am Coll Surg 181:483

    CAS  PubMed  Google Scholar 

  28. Zimmeman SE, Smith FP, Scein PS (1981) Chemotherapy of pancreatic carcinoma. Cancer 47:1724

    Google Scholar 

  29. Gastrointestinal Tumor Study Group (1981) Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. Cancer 48:1705

    Google Scholar 

  30. Cantore M, Fiorentini G, Bassi C, et al (1997) Intra-arterial chemotherapy for stage-III/IV pancreatic cancer. Dig Surg 14:113

    Google Scholar 

  31. Cohen L, Hendrickson FR, Lennox AJ, Kroc TK, Hatcher MA, Bennett BR (1996) Pancreatic cancer: Treatment with neutron irradiation alone and with chemotherapy. Radiology 200:627

    CAS  PubMed  Google Scholar 

  32. Palmer KR, Kerr M, Knowles G, Cull A, Carter DC, Leonard RCF (1994) Chemotherapy prolongs survival in inoperable pancreatic carcinoma. Br J Surg 81:882

    CAS  PubMed  Google Scholar 

  33. Evans TRJ, Lofts FJ, Mansi JL, Glees JP, Dalgleish AG, Knight MJ (1996) A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer. Br J Cancer 73:1260

    CAS  PubMed  Google Scholar 

  34. Smith L, Gazet J (1980) Intra-arterial chemotherapy for patients with inoperable carcinoma of the pancreas. Ann R Coll Surg Engl 62:208

    Google Scholar 

  35. Ishikawa O, Ohigashi H, Sasaki Y, et al (1994) Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas. Am J Surg 168:361

    Article  CAS  PubMed  Google Scholar 

  36. Ishida H, Makino T, Kobayashi M, Tsuneoka K (1983) Laparoscopic measurement of pancreatic blood flow. Endoscopy 15:107

    CAS  PubMed  Google Scholar 

  37. Aigner KR, Muller H, Basserman R (1990) Intra-arterial chemotherapy with MMC, CDDP and 5-FU for nonresectable pancreatic cancer. A phase II study. Reg Cancer Treat 3:1

    Google Scholar 

  38. Muchmore JH (1995) Treatment of advanced pancreatic cancer with regional chemotherapy plus hemofiltration. Int J Pancreatol 7:209

    Google Scholar 

  39. Theodors A, Bukowski R, Hewlett J, Livingston RB, Weick JK (1982) Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study. Am J Clin Oncol 5:555

    CAS  PubMed  Google Scholar 

  40. Gansauge F, Link KH, Rilinger N, Kunz R, Beger HG (1995) Regional chemotherapy in advanced pancreatic carcinoma. Med Klin 90:501

    CAS  Google Scholar 

  41. Link KH, Gansauge F, Rilinger N, Beger HG (1997) Celiac artery adjuvant chemotherapy. Results of a prospective trial. Int J Pancreatol 21:65

    CAS  PubMed  Google Scholar 

  42. Cantore M, Fiorentini G, Bassi C, et al (1996) Intra-arterial chemotherapy for locally advanced and metastatic pancreatic cancer. J Chemother 8:80

    Google Scholar 

  43. Link KH, Gansauge F, Gorich J, Leder GH, Rilinger N, Beger HG (1997) Palliative and adjuvant regional chemotherapy in pancreatic cancer. Eur J Surg Oncol 23:409

    Article  CAS  PubMed  Google Scholar 

  44. Beger HG, Gansauge F, Buchler MW, Link KH (1999) Intra-arterial adjuvant chemotherapy after pancreaticoduodectomy for pancreatic cancer: Significant reduction in occurrence of liver metastases. World J Surg 23:946

    Article  CAS  PubMed  Google Scholar 

  45. Archer SG, Gray BN (1989) Vascularization of small liver metastases. Br J Surg 76:545

    CAS  PubMed  Google Scholar 

  46. Ackerman NB (1974) The blood supply of experimental liver metastases: IV, changes in vascularity with increasing tumor growth. Surgery 75:589

    CAS  PubMed  Google Scholar 

  47. Kemeny NE, (1995) Regional chemotherapy of colorectal cancer. Eur J Cancer 31A:1271

    CAS  PubMed  Google Scholar 

  48. Kerr DJ, McArdle CS, Ledermann J, et al (2003) Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: A multicentre randomized trial. Lancet 361:368

    CAS  PubMed  Google Scholar 

  49. Rougier PH, Laplanche A, Haguier M, et al (1992) Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial. J Clin Oncol 10:1112

    CAS  PubMed  Google Scholar 

  50. Griffin JF, Smally SR, Jewell W, et al (1990) Pattern of failure after curative resection of pancreatic carcinoma. Cancer 66:56

    CAS  PubMed  Google Scholar 

  51. Fortner JG, Klimstra DS, Senie RT, et al (1996) Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy. Am Surg 223:147

    CAS  Google Scholar 

  52. Honma H, Doi T, Mezawa S, et al (2000) A novel infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization. Cancer 89:303

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic Radiology, Kumamoto University Graduate School of Medical and Pharmaceutical Sciences, 1-1-1 Honjo, Kumamoto, 860-8505, Japan

    O. Ikeda, S. Kusunoki, K. Kudoh & Y. Yamashita

  2. Department of Gastroenterological Surgery, Kumamoto University Graduate School of Medical and Pharmaceutical Sciences, 1-1-1 Honjo, Kumamoto, 860-8505, Japan

    H. Takamori, T. Tsuji & K. Kanemitsu

Authors
  1. O. Ikeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Kusunoki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Kudoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Takamori
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Tsuji
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. Kanemitsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Y. Yamashita
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O. Ikeda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ikeda, O., Kusunoki, S., Kudoh, K. et al. Evaluation of the Efficacy of Combined Continuous Arterial Infusion and Systemic Chemotherapy for the Treatment of Advanced Pancreatic Carcinoma. Cardiovasc Intervent Radiol 29, 362–370 (2006). https://doi.org/10.1007/s00270-004-7177-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-004-7177-1

Keywords

Search

Navigation